| scholarly article | Q13442814 |
| P50 | author | David T. Curiel | Q64384545 |
| Karen Aboody | Q90051514 | ||
| P2093 | author name string | Xueli Liu | |
| Maciej S Lesniak | |||
| Rachael Mooney | |||
| Diana Machado | |||
| Revathiswari Tirughana | |||
| Mohamed Hammad | |||
| Jennifer Batalla-Covello | |||
| Joanna Gonzaga | |||
| Asma Abdul Majid | |||
| P2860 | cites work | Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions | Q26775038 |
| Survivin: role in normal cells and in pathological conditions | Q28188930 | ||
| The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 | ||
| Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
| Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies | Q29616780 | ||
| Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array | Q30945232 | ||
| Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma | Q33585559 | ||
| Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data | Q33761673 | ||
| Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. | Q33781472 | ||
| Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer | Q33932032 | ||
| Cancer of the ovary | Q34375262 | ||
| Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma | Q34411569 | ||
| Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction. | Q34943738 | ||
| Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. | Q35238250 | ||
| A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma | Q35256949 | ||
| Oncolytic virotherapy for ovarian cancer | Q35597082 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors | Q35857215 | ||
| Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model | Q35973436 | ||
| Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds | Q36387908 | ||
| Striking out at disseminated metastases: the systemic delivery of oncolytic viruses. | Q36586716 | ||
| Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer | Q36597119 | ||
| A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy | Q36976226 | ||
| Evaluating cell lines as tumour models by comparison of genomic profiles | Q37025950 | ||
| Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine | Q37035678 | ||
| Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors | Q37059464 | ||
| Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role. | Q37085878 | ||
| Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer. | Q37286038 | ||
| Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies | Q37396577 | ||
| Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model | Q37455627 | ||
| Oncolytic virus as a cancer stem cell killer: progress and challenges | Q38881477 | ||
| Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors. | Q38931271 | ||
| Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients. | Q39097305 | ||
| A novel CRAd in combination with cisplatin enhanced the antitumor efficacy in ovarian cancer | Q39443613 | ||
| High-dose cisplatin therapy in ovarian cancer. | Q39838124 | ||
| Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling | Q40002631 | ||
| Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma | Q40107189 | ||
| Effects of chemotherapy and/or radiotherapy on survivin expression in ovarian cancer | Q40187794 | ||
| Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors. | Q40459504 | ||
| Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice. | Q43281285 | ||
| Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms. | Q45722656 | ||
| Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus | Q45862568 | ||
| Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies | Q45863222 | ||
| Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma | Q45866325 | ||
| Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients | Q45867352 | ||
| Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types | Q45888027 | ||
| Loss of Survivin in Intestinal Epithelial Progenitor Cells Leads to Mitotic Catastrophe and Breakdown of Gut Immune Homeostasis. | Q52886504 | ||
| Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma | Q74466041 | ||
| A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer | Q81561698 | ||
| P2507 | corrigendum / erratum | Erratum: Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer | Q96642222 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| Adenoviridae | Q193447 | ||
| oncolytic virus | Q1560099 | ||
| neural stem cell | Q2944097 | ||
| Neural stem cells | Q28202913 | ||
| Oncolytic virotherapy | Q38025263 | ||
| P304 | page(s) | 79-92 | |
| P577 | publication date | 2019-03-29 | |
| P1433 | published in | Molecular therapy oncolytics | Q27726823 |
| P1476 | title | Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer | |
| P478 | volume | 12 |
| Q92221478 | Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study |
| Q89704638 | Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency |
| Q98292349 | Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer Model |
| Q89769530 | Oncolytic Viruses and the Immune System: The Dynamic Duo |
| Q92223350 | Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances |
| Q99576115 | Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer |
Search more.